Applications of bupivacaine in the non-surgical treatments of strabismus: a review.

IF 0.8 Q4 OPHTHALMOLOGY
Mohammad Yaser Kiarudi, Seyed Hossein Ghavami Shahri, Acieh Es'haghi, Bahare Gharib, Mohammad-Reza Ansari-Astaneh
{"title":"Applications of bupivacaine in the non-surgical treatments of strabismus: a review.","authors":"Mohammad Yaser Kiarudi,&nbsp;Seyed Hossein Ghavami Shahri,&nbsp;Acieh Es'haghi,&nbsp;Bahare Gharib,&nbsp;Mohammad-Reza Ansari-Astaneh","doi":"10.1080/09273972.2022.2135743","DOIUrl":null,"url":null,"abstract":"<p><p>Bupivacaine (BUP) is an anesthetic from the family of aminoacyl anesthetics and has the highest myotoxicity among other groups of anesthetics. Intramuscular injection of BUP first causes acute libriform lysis and subsequently with the regeneration process, stronger myofibrils are formed within 3-4 weeks. Satellite cells, which are actually myogenic stem cells, are preserved in the early stage and during the destruction of muscle fibers. In fact, these cells are responsible for the subsequent regeneration of fibers. BUP is one of the few medicines that is able to increase muscle strength. In animal studies on rabbits, a decrease has been observed in the diameter of the global layer in the first week and an increase in type-I myosin occurs after 60 days, especially in the global muscle layer. There are numerous studies according to BUP injection for the non-surgical management of horizontal strabismus. To intensify the effects of the injection, botulinum toxin injection can also be used simultaneously in the antagonist muscles. In general, although the rate of improvement in strabismus varied among different studies, BUP injection alone corrects about 5-8 prism diopters. Together with botulinum toxin, BUP corrects about 15 prism diopters. The stability of this improvement is up to 10 years after injection. No significant difference has been observed in response rate between patients with esotropia and exotropia. Unlike the large molecule of botulinum toxin, which spreads slowly to its site of action, the BUP molecule is small and must be in direct contact with myofibrils before absorption into the bloodstream to exert its effect. Therefore, the injection volume should be about 3 cc with a concentration of 0.75 g per deciliter. Although BUP is promising non-surgical strabismus management, especially in small angle and residual horizontal strabismus, however, it has its own limitations. The need for direct infusion of a relatively large volume of BUP may be one of its major drawbacks that limits its usage in an office method.</p>","PeriodicalId":51700,"journal":{"name":"Strabismus","volume":null,"pages":null},"PeriodicalIF":0.8000,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Strabismus","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/09273972.2022.2135743","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Bupivacaine (BUP) is an anesthetic from the family of aminoacyl anesthetics and has the highest myotoxicity among other groups of anesthetics. Intramuscular injection of BUP first causes acute libriform lysis and subsequently with the regeneration process, stronger myofibrils are formed within 3-4 weeks. Satellite cells, which are actually myogenic stem cells, are preserved in the early stage and during the destruction of muscle fibers. In fact, these cells are responsible for the subsequent regeneration of fibers. BUP is one of the few medicines that is able to increase muscle strength. In animal studies on rabbits, a decrease has been observed in the diameter of the global layer in the first week and an increase in type-I myosin occurs after 60 days, especially in the global muscle layer. There are numerous studies according to BUP injection for the non-surgical management of horizontal strabismus. To intensify the effects of the injection, botulinum toxin injection can also be used simultaneously in the antagonist muscles. In general, although the rate of improvement in strabismus varied among different studies, BUP injection alone corrects about 5-8 prism diopters. Together with botulinum toxin, BUP corrects about 15 prism diopters. The stability of this improvement is up to 10 years after injection. No significant difference has been observed in response rate between patients with esotropia and exotropia. Unlike the large molecule of botulinum toxin, which spreads slowly to its site of action, the BUP molecule is small and must be in direct contact with myofibrils before absorption into the bloodstream to exert its effect. Therefore, the injection volume should be about 3 cc with a concentration of 0.75 g per deciliter. Although BUP is promising non-surgical strabismus management, especially in small angle and residual horizontal strabismus, however, it has its own limitations. The need for direct infusion of a relatively large volume of BUP may be one of its major drawbacks that limits its usage in an office method.

布比卡因在斜视非手术治疗中的应用综述。
布比卡因(Bupivacaine, BUP)是氨基酰基麻醉药家族的一种麻醉剂,在其他麻醉药组中具有最高的肌毒性。肌内注射BUP首先引起急性纤原溶解,随后随着再生过程,在3-4周内形成较强的肌原纤维。卫星细胞,实际上是肌源性干细胞,在肌纤维破坏的早期阶段被保存下来。事实上,这些细胞负责随后的纤维再生。BUP是少数几种能够增加肌肉力量的药物之一。在对家兔进行的动物研究中,第一周观察到全肌层直径减小,60天后出现i型肌球蛋白增加,特别是在全肌层。目前有大量研究表明BUP注射用于非手术治疗水平斜视。为了加强注射的效果,肉毒杆菌毒素注射也可以同时用于拮抗剂肌肉。一般来说,虽然斜视的改善率在不同的研究中有所不同,但单独注射BUP可矫正约5-8棱镜屈光度。与肉毒杆菌毒素一起,BUP矫正了大约15个棱镜屈光度。这种改善的稳定性在注射后长达10年。内斜视和外斜视患者的反应率无显著差异。与大分子肉毒杆菌毒素不同,肉毒杆菌毒素会缓慢地扩散到作用部位,BUP分子很小,在被血液吸收之前必须与肌原纤维直接接触才能发挥作用。因此,注射量应为3cc左右,浓度为0.75 g /分升。虽然BUP是一种很有前途的非手术斜视治疗方法,特别是在小角度斜视和残余水平斜视中,但它也有其局限性。需要直接注入相对大量的BUP可能是其主要缺点之一,限制了其在办公室方法中的使用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Strabismus
Strabismus OPHTHALMOLOGY-
CiteScore
1.60
自引率
11.10%
发文量
30
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信